Long-term outcomes of prophylactic autologous pericardium tricuspid annuloplasty:propensity score matching of 832 patients with rheumatic heart disease
10.3969/j.issn.1006-5725.2018.09.017
- VernacularTitle:自体心包片预防性三尖瓣成形术远期随访结果——832例风湿性心脏病患者倾向性匹配分析
- Author:
Jian ZHANG
1
;
Guiyou LIANG
;
Daxing LIU
;
Yan REN
;
Hao ZHOU
;
Gehong PENG
;
Wenhong TAO
Author Information
1. 遵义医学院附属医院心血管外科 贵州563003
- Keywords:
rheumatic heart disease;
tricuspid valve annuloplasty;
long-term outcome
- From:
The Journal of Practical Medicine
2018;34(9):1476-1480
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the safety and longterm outcomes of prophylactic autologous pericardium tricuspid valve annuloplasty(TVA)in patients with rheumatic heart disease(RHD). Methods A total of 832 patients with RHD were enrolled in this study ,including 146 patients with mild FTR but without TVA(observation group);434 patients with mild FTR underwent TVA(control group A)and 434 patients with moderate or severe FTR underwent TVA(control group B). Propensity score and survival analysis were used to evaluate perioperative safety ,FTR progression ,CHF and MACCE incidence after prophylactic TVA. Results A total of 192 patients were successfully matched. There was no significant difference in the perioperative complications between the observation group and the control groups(P>0.05). The progression rate of FTR in the observation group was significantly lower than that in the control groups (P = 0.005 & 0.032 ). There was no significant difference in the incidence of CHF and MACCE events between the observation group and the control groups (P > 0.05). Conclusions The treatment strategy of prophylactic autologous pericardium TVA at the time of left heart valve surgery for patients with RHD doesn′t increase operation costs ,perioperative complications and mortality ,but effectively prevent postoperative FTR recurrence or progression.
